Eos Advisory led the Series A round alongside new and existing backers to fund international expansion and commercialisation.
"The Dxcover technology combines deep technical innovation with machine learning to radically change the diagnostic landscape. Over the last three years they have conclusively shown the accuracy and ease of use of their diagnostic test across multiple cancer indications. This is very much aligned with Eos’ approach to investing in innovation that has the potential to impact positively in people's lives. More recently the team at Dxcover have focused on building a world class international team on both sides of the Atlantic. This funding round is very much about commercialization in both the UK and the US."
E3 Capital led the funding round with backing from Fireball Capital, Atlantic Bridge, Globalive, and JLR Star to support platform expansion.
"The investment will enable us to accelerate the development and expansion of our platform’s capabilities to comprehensively tackle some of the more complex monitoring, reporting, and verification challenges faced by various industries today."
The round was led by We Venture Capital and Cross-Border Impact Ventures to support the development of liquid biopsy tests.
"The power of the OXcan proteomics biomarker discovery platform and the data generated by Oxcan stand out against the backdrop of other liquid biopsy companies, indicating a truly superior performance in the identification of early stage lung cancer"
Osage Ventures Partners led the Series A round to support product development and team expansion.
"Most eCommerce brands follow a familiar playbook, drive traffic, offer discounts for email sign-ups, maybe test a traffic de-anonymizer, hope for purchases and remarket those that don't. But this underutilises the most impactful and brief moment for building marketing lists, the checkout. Since focusing on the eCommerce market, we've discovered something extraordinary, when done right, compliance isn't just about protection, it's about growth. By dynamically optimising consent language at the checkout, based on visitor location and marketing channel, we're helping merchants achieve remarkable results in terms of increased opt-in rates, marketing contacts, and additional revenue generated through repeat purchases."
